Lundbeck
HLUN-B.CO
#2663
Rank
A$9.52 B
Marketcap
A$9.60
Share price
-0.50%
Change (1 day)
12.62%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): A$0.93

According to Lundbeck's latest financial reports the company's current EPS (TTM) is A$0.88. an increase over its 2024 EPS that were of A$0.64.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025A$0.7314.5%
2024A$0.6429.29%
2023A$0.4923.09%
2022A$0.4037.26%
2021A$0.29-84.61%
2020A$1.90-24.61%
2019A$2.52-42.06%
2018A$4.3540.7%
2017A$3.09146.26%
2016A$1.26-120.48%
2015A-$6.133231.32%
2014A-$0.18-115.78%
2013A$1.17-23.36%
2012A$1.52-48.01%
2011A$2.93-9.68%
2010A$3.2413.72%
2009A$2.8524.32%
2008A$2.29-6.05%
2007A$2.4481.77%
2006A$1.34-16.76%
2005A$1.61-17.58%
2004A$1.96